Failure of Antiarrhythmic Drugs to Prevent Experimental Reperfusion Ventricular Fibrillation

Circulation - United States
doi 10.1161/01.cir.63.1.70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Adherence to Guideline Recommendations for Antiarrhythmic Drugs in Atrial Fibrillation

American Heart Journal
Cardiovascular MedicineCardiology
2013English

Class 1C Antiarrhythmic Drugs in Atrial Fibrillation and Coronary Artery Disease

Journal of Cardiovascular Electrophysiology
Cardiovascular MedicinePhysiologyCardiology
2020English

Antiarrhythmic Drug Therapy for Atrial Fibrillation in Patients With Left Ventricular Dysfunction

Japanese Journal of Electrocardiology
2014English

Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Symptomatic Atrial Fibrillation

JAMA - Journal of the American Medical Association
Medicine
2005English

Pharmacological Effects of Antiarrhythmic Drugs

Archives of Internal Medicine
1998English

Therapeutic Drug Monitoring: Antiarrhythmic Drugs

British Journal of Clinical Pharmacology
Pharmacology
1998English

Network Meta-Analysis on the Efficacy of Antiarrhythmic Drugs for the Termination of Ventricular Tachycardia

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Effects of E-4031 on Atrial Fibrillation Threhold: A Comparative Study With Class I Antiarrhythmic Drugs.

Japanese Journal of Electrocardiology
1994English

Antiarrhythmic Drug Therapy for Atrial Fibrillation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy